Global Influenza Market (H1N1 Vaccines and Others) by Product (Influenza Vaccines and Influenza Drugs): Global Industry Perspective, Comprehensive Analysis and Forecast 2014 – 2020

Global Influenza Market is Expected to Reach USD 6.87 Billion in 2020.key players in this market include AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Sanofi-Pasteur and others.

The report provides estimate, forecast and analysis for the influenza market over a global and regional level. The influenza market is in terms of revenue (USD million), for the period from 2015 to 2020, whereas study provides significant information related to market. The study also offers important market dynamics such as Market size, production forecasts along with key factors driving and restraining the market. Additionally, the report includes the study of opportunities, which are available in the influenza market across global level.

This report provides decisive view on the influenza market to the readers, which describes industry growth rate, industry capacity, and industry structure. Study of Porter’s Five Forces model for the influenza market helps to understand competitive landscape in the market. Some additional parameters such as attractiveness analysis, wherein product segments are benchmarked based on their market size and growth rate, in which different segments are benchmarked related to their market size, growth rate and general attractiveness.

The research provides influenza market bifurcating it into influenza viruses and its vaccines. Influenza viruses includes influenza type A, influenza type B, influenza type C. All the market distribution on products and application has been analyzed based on present and future trends and the market is estimated from 2015 to 2020.

The report provides global scenario of Influenza Market comprehensive overview and market figures. Moreover, study gives the current and expected demand for main region including Americas, EMEA and Asia Pacific. The report provides detailed bifurcation of global influenza market on the basis of products type such as influenza vaccines and influenza drugs. Similar bifurcation has been provided for the individual region.

The report covers detailed competitive scenario including the market share and company overviews, financial revenues of the key participants to develop their positions in the global market. Some key players in this market include AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Sanofi-Pasteur and others.

This report segments the global market as follows:

  • Influenza Market – Product Segment Analysis
  • Influenza Vaccines
  • Influenza Drugs

Influenza Market – Regional Analysis

  • Americas
  • EMEA (Europe, Middle East and Africa)
  • Asia Pacific
  • Chapter 1. Preface
    • 1.1. Report description and scope
    • 1.2. Research methodology
      • 1.2.1. Market research process
    • 1.3. List of abbreviations
  • Chapter 2. Executive Summary
    • 2.1. Global Influenza Market Revenue, 2014 – 2020 (USD Billion)
    • 2.2. Influenza Market: Snapshot
  • Chapter 3. Influenza Market – Market Dynamics
    • 3.1. Introduction
    • 3.2. Introduction and Classification
      • 3.2.1. Seasonal Influenza
      • 3.2.2. Pandemic Influenza
      • 3.2.3. Zoonotic or Variant Influenza
    • 3.3. Influenza Season
    • 3.4. Geographical Distribution
    • 3.5. Market Drivers
      • 3.5.1. Increase in Awareness Regarding Influenza
      • 3.5.2. Increase in Industry-Academia Collaborations
      • 3.5.3. Global Action Plan for Influenza Vaccines
    • 3.6. Market Restraints
    • 3.7. Market Trends
    • 3.8. Porter’s Five Forces Analysis
  • Chapter 4. Market Landscape
    • 4.1. Buying Criteria
    • 4.2. Vendor landscape
      • 4.2.1. competitive Scenario
        • 4.2.1.1. Key News
        • 4.2.1.2. M&A’s
      • 4.2.2. Market Share Analysis
        • 4.2.2.1. Sanofi Pasteur
        • 4.2.2.2. F. Hoffmann-La Roche
        • 4.2.2.3. GlaxoSmithKline
        • 4.2.2.4. AstraZeneca
        • 4.2.2.5. Novartis
      • 4.2.3. Other Prominent Vendors
  • Chapter 5. Market Segmentation by Type of Influenza Virus
    • 5.1. Influenza Type A Viruses
    • 5.2. Influenza Type B Viruses
    • 5.3. Influenza Type C Viruses
  • Chapter 6. Global H1N1 Vaccines Market
    • 6.1. Market Share
    • 6.2. Market Segmentation
    • 6.3. Market Size and Forecast
    • 6.4. Geographical Segmentation
  • Chapter 7. Market Segmentation by Product Type
  • Chapter 8. Global Influenza Drugs Market
    • 8.1. Market Segmentation
      • 8.1.1. M2 Protein inhibitors
      • 8.1.2. Neuraminidase Inhibitors
    • 8.2. Market Size and Forecast
    • 8.3. Key Approved Influenza Drugs
      • 8.3.1. In US
      • 8.3.2. In EU
  • Chapter 9. Global Influenza Vaccines Market
    • 9.1. Market Segmentation
    • 9.2. Market Size and Forecast
    • 9.3. WHO Recommendation
    • 9.4. Key Approved Influenza Vaccines
      • 9.4.1. In US
      • 9.4.2. In EU
  • Chapter 10. Geographical Segmentation
  • Chapter 11. Company Profiles
    • 11.1. AstraZeneca
      • 11.1.1. Key Facts
      • 11.1.2. Business Description
      • 11.1.3. Business Segmentation
      • 11.1.4. Business Strategy
      • 11.1.5. Business Segmentation by Revenue
      • 11.1.6. Revenue Comparison 2011-2013
      • 11.1.7. Geographical Segmentation by Revenue
      • 11.1.8. Key Development
      • 11.1.9. SWOT Analysis
    • 11.2. F. Hoffmann-La Roche
      • 11.2.1. Key Facts
      • 11.2.2. Business Description
      • 11.2.3. Business Segmentation by Revenue
      • 11.2.4. Geographical Segmentation by Revenue
      • 11.2.5. Business Strategy
      • 11.2.6. Key Development
      • 11.2.7. SWOT Analysis
    • 11.3. GlaxoSmithKline
      • 11.3.1. Key Facts
      • 11.3.2. Business Description
      • 11.3.3. Business Segmentation
      • 11.3.4. Business Segmentation by Revenue
      • 11.3.5. Geographical Segmentation by Revenue
      • 11.3.6. Pipeline Products
      • 11.3.7. Business Strategy
      • 11.3.8. Key Development
      • 11.3.9. SWOT Analysis
    • 11.4. Novartis
      • 11.4.1. Key Facts
      • 11.4.2. Business Description
      • 11.4.3. Business Segment at ion by Revenue 2013 103
      • 11.4.4. Business Segmentation Revenue Comparison 2012-2013
      • 11.4.5. Geographical Segmentation by Revenue
      • 11.4.6. Business Strategy
      • 11.4.7. Key Development
      • 11.4.8. SWOT Analysis
    • 11.5. Sanofi Pasteur
      • 11.5.1. Key facts
      • 11.5.2. Business Description
      • 11.5.3. Business Strategy
      • 11.5.4. Key Development
      • 11.5.5. SWOT Analysis

* Indicates required field.

Your Name*

Your Email*

Telephone Number*

Name of company*

Country Name*

How can we help you?

Prove You are Human*

captcha
Enter Capcha Image Properly



Share this Post

Related Posts

Checking...

Ouch! There was a server error.
Retry »

Sending message...

Enquiry Form

Fill in the form below and we will be in touch soon

Create Account



Log In Your Account